A mobile app to screen for neurocognitive impairment: Preliminary validation of neuroscreen among HIV-infected South African adults

JMIR mHealth and uHealth

Volumn 6, Issue 1, 2018, Pages

  Robbins, Reuben N ^a   Gouse, Hetta ^b   Brown, Henry G ^c   Ehlers, Andries ^c   Scott, Travis M ^d   Leu, Cheng Shiun ^a   Remien, Robert H ^a   Mellins, Claude A ^a   Joska, John A ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c Envisage IT   (South Africa)

^d FORDHAM UNIVERSITY   (United States)

Author keywords

App; HIV; Impairment; Lay health workers; Neurocognitive; Neuropsychology; Resource limited settings; South Africa; Tablet

Indexed keywords

EID: 85060496072     PISSN: None     EISSN: 22915222     Source Type: Journal    
DOI: 10.2196/mhealth.9148     Document Type: Article

References (51)

1. UNAIDS. 2017 Oct 10. AIDSInfo URL: http://aidsinfo.unaids.org/[accessed 2017-10-10] [WebCite Cache ID 6u6ydn7i0]
2. Joska JA, Westgarth-Taylor J, Myer L, Hoare J, Thomas KG, Combrinck M, et al. Characterization of HIV-associated neurocognitive disorders among individuals starting antiretroviral therapy in South Africa. AIDS Behav 2011 Aug;15(6):1197-1203. [doi: 10.1007/s10461-010-9744-6] [Medline: 20614176]
3. Joska JA, Westgarth-Taylor J, Hoare J, Thomas KG, Paul R, Myer L, et al. Neuropsychological outcomes in adults commencing highly active anti-retroviral treatment in South Africa: a prospective study. BMC Infect Dis 2012 Feb 15;12:39 [FREE Full text] [doi: 10.1186/1471-2334-12-39] [Medline: 22335937]
4. Becker JT, Lopez OL, Dew MA, Aizenstein HJ. Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS 2004 Jan 01;18 Suppl 1:S11-S18. [Medline: 15075493]
5. Bonnet F, Amieva H, Marquant F, Bernard C, Bruyand M, Dauchy FA, S CO3 Aquitaine Cohort. Cognitive disorders in HIV-infected patients: are they HIV-related? AIDS 2013 Jan 28;27(3):391-400. [doi: 10.1097/QAD.0b013e32835b1019] [Medline: 23079813]
6. Grant I, Sacktor N, McArthur J. HIV neurocognitive disorders. In: Gendelman HE, Grant I, Everall IP, Fox HS, Gelbard HA, Lipton SA, et al, editors. The Neurology of AIDS. Oxford: Oxford University Press; 2005:357-373.
7. Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, et al. The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1995 May;1(3):231-251. [Medline: 9375218]
8. Simioni S, Cavassini M, Annoni J, Rimbault AA, Bourquin I, Schiffer V, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 2010 Jun 01;24(9):1243-1250. [doi: 10.1097/QAD.0b013e3283354a7b] [Medline: 19996937]
9. Grant I. Neurocognitive disturbances in HIV. Int Rev Psychiatry 2008 Feb;20(1):33-47. [doi: 10.1080/09540260701877894] [Medline: 18240061]
10. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, CHARTER Group, HNRC Group. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 2011 Feb;17(1):3-16 [FREE Full text] [doi: 10.1007/s13365-010-0006-1] [Medline: 21174240]
11. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007 Oct 30;69(18):1789-1799 [FREE Full text] [doi: 10.1212/01.WNL.0000287431.88658.8b] [Medline: 17914061]
12. Hinkin CH, Castellon SA, Durvasula RS, Hardy DJ, Lam MN, Mason KI, et al. Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology 2002 Dec 24;59(12):1944-1950 [FREE Full text] [Medline: 12499488]
13. Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS 2004 Jan 01;18 Suppl 1:S19-S25 [FREE Full text] [Medline: 15075494]
14. Vivithanaporn P, Heo G, Gamble J, Krentz HB, Hoke A, Gill MJ, et al. Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study. Neurology 2010 Sep 28;75(13):1150-1158 [FREE Full text] [doi: 10.1212/WNL.0b013e3181f4d5bb] [Medline: 20739646]
15. Ettenhofer ML, Foley J, Castellon SA, Hinkin CH. Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS. Neurology 2010 Apr 13;74(15):1217-1222 [FREE Full text] [doi: 10.1212/WNL.0b013e3181d8c1ca] [Medline: 20220123]
16. Ettenhofer ML, Hinkin CH, Castellon SA, Durvasula R, Ullman J, Lam M, et al. Aging, neurocognition, and medication adherence in HIV infection. Am J Geriatr Psychiatry 2009 Apr;17(4):281-290 [FREE Full text] [doi: 10.1097/JGP.0b013e31819431bd] [Medline: 19307857]
17. Anand P, Springer SA, Copenhaver MM, Altice FL. Neurocognitive impairment and HIV risk factors: a reciprocal relationship. AIDS Behav 2010 Dec;14(6):1213-1226 [FREE Full text] [doi: 10.1007/s10461-010-9684-1] [Medline: 20232242]
18. Iudicello JE, Woods SP, Cattie JE, Doyle K, Grant I, HIV Neurobehavioral Research Program Group. Risky decision-making in HIV-associated neurocognitive disorders (HAND). Clin Neuropsychol 2013;27(2):256-275 [FREE Full text] [doi: 10.1080/13854046.2012.740077] [Medline: 23181946]
19. Thames AD, Streiff V, Patel SM, Panos SE, Castellon SA, Hinkin CH. The role of HIV infection, cognition, and depression in risky decision-making. J Neuropsychiatry Clin Neurosci 2012;24(3):340-348 [FREE Full text] [doi: 10.1176/appi.neuropsych.11110340] [Medline: 23037648]
20. Gorman AA, Foley JM, Ettenhofer ML, Hinkin CH, van GWG. Functional consequences of HIV-associated neuropsychological impairment. Neuropsychol Rev 2009 Jun;19(2):186-203 [FREE Full text] [doi: 10.1007/s11065-009-9095-0] [Medline: 19472057]
21. Kamminga J, Cysique LA, Lu G, Batchelor J, Brew BJ. Validity of cognitive screens for HIV-associated neurocognitive disorder: a systematic review and an informed screen selection guide. Curr HIV/AIDS Rep 2013 Dec;10(4):342-355 [FREE Full text] [doi: 10.1007/s11904-013-0176-6] [Medline: 24072534]
22. Mind Exchange Working Group. Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program. Clin Infect Dis 2013 Apr;56(7):1004-1017 [FREE Full text] [doi: 10.1093/cid/cis975] [Medline: 23175555]
23. Cysique L, Bain M, Lane T, Brew B. Management issues in HIV-associated neurocognitive disorders. NBHIV 2012 Jul;4:63-73. [doi: 10.2147/NBHIV.S30466]
24. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global Report: UNAIDS Report on the Global AIDS Epidemic 2013. Geneva, Switzerland: UNAIDS; 2013.
25. World Health Statistics: Global Health Indicators. Geneva, Switzerland: World Health Organization; 2010.
26. Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, HNRC Group. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 2004 May;10(3):317-331. [doi: 10.1017/S1355617704102130] [Medline: 15147590]
27. Robbins RN, Remien RH, Mellins CA, Joska JA, Stein DJ. Screening for HIV-associated dementia in South Africa: potentials and pitfalls of task-shifting. AIDS Patient Care STDS 2011 Oct;25(10):587-593 [FREE Full text] [doi: 10.1089/apc.2011.0154] [Medline: 21919734]
28. Breuer E, Stoloff K, Myer L, Seedat S, Stein DJ, Joska J. Reliability of the lay adherence counsellor administered substance abuse and mental illness symptoms screener (SAMISS) and the International HIV Dementia Scale (IHDS) in a primary care HIV clinic in Cape Town, South Africa. AIDS Behav 2012 Aug;16(6):1464-1471. [doi: 10.1007/s10461-011-0067-z] [Medline: 22001934]
29. Zipursky AR, Gogolishvili D, Rueda S, Brunetta J, Carvalhal A, McCombe JA, et al. Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature. AIDS 2013 Sep 24;27(15):2385-2401 [FREE Full text] [doi: 10.1097/QAD.0b013e328363bf56] [Medline: 23751261]
30. Joska JA, Westgarth-Taylor J, Hoare J, Thomas KG, Paul R, Myer L, et al. Validity of the International HIV Dementia Scale in South Africa. AIDS Patient Care STDS 2011 Feb;25(2):95-101. [doi: 10.1089/apc.2010.0292] [Medline: 21214343]
31. Joska JA, Witten J, Thomas KG, Robertson C, Casson-Crook M, Roosa H, et al. A comparison of five brief screening tools for HIV-associated neurocognitive disorders in the USA and South Africa. AIDS Behav 2016 Aug;20(8):1621-1631. [doi: 10.1007/s10461-016-1316-y] [Medline: 26860536]
32. Callaghan M, Ford N, Schneider H. A systematic review of task-shifting for HIV treatment and care in Africa. Hum Resour Health 2010 Mar 31;8:8. [doi: 10.1186/1478-4491-8-8] [Medline: 20356363]
33. Bekker L, Myer L, Orrell C, Lawn S, Wood R. Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa. S Afr Med J 2006 Apr;96(4):315-320 [FREE Full text] [Medline: 16670804]
34. Zachariah R, Ford N, Philips M, Lynch S, Massaquoi M, Janssens V, et al. Task shifting in HIV/AIDS: opportunities, challenges and proposed actions for sub-Saharan Africa. Trans R Soc Trop Med Hyg 2009 Jun;103(6):549-558. [doi: 10.1016/j.trstmh.2008.09.019] [Medline: 18992905]
35. Robbins RN, Brown H, Ehlers A, Joska JA, Thomas KG, Burgess R, et al. A smartphone app to screen for HIV-related neurocognitive impairment. J Mob Technol Med 2014 Feb 01;3(1):23-26 [FREE Full text] [doi: 10.7309/jmtm.3.1.5] [Medline: 24860624]
36. Robbins RN, Mellins CA, Leu C, Rowe J, Warne P, Abrams EJ, et al. Enhancing lay counselor capacity to improve patient outcomes with multimedia technology. AIDS Behav 2015 Jun;19 Suppl 2:163-176. [doi: 10.1007/s10461-014-0988-4] [Medline: 25566763]
37. Remien RH, Mellins CA, Robbins RN, Kelsey R, Rowe J, Warne P, et al. Masivukeni: development of a multimedia based antiretroviral therapy adherence intervention for counselors and patients in South Africa. AIDS Behav 2013 Jul;17(6):1979-1991 [FREE Full text] [doi: 10.1007/s10461-013-0438-8] [Medline: 23468079]
38. Gouse H, Henry M, Robbins RN, Lopez-Rios J, Mellins CA, Remien RH, et al. Psychosocial aspects of ART counseling: a comparison of HIV beliefs and knowledge in PMTCT and ART-naive women. J Assoc Nurses AIDS Care 2017;28(4):504-517. [doi: 10.1016/j.jana.2017.03.002] [Medline: 28377125]
39. Benedict RH, Schretlen D, Groninger L, Brandt J. Hopkins Verbal Learning Test-Revised: normative data and analysis of inter-form and test-retest reliability. Clinical Neuropsychol 1998 Feb 1;12(1):43-55. [doi: 10.1076/clin.12.1.43.1726]
40. Benedict RH. Brief Visuospatial Memory Test-Revised: Professional Manual. Odessa, FL: Psychological Assessment Resources, Inc; 1997.
41. D'Elia L, Satz P, Uchiyama C, White T. Color Trails Test. Odessa, FL: Psychological Assessment Resources, Inc; 1996.
42. Kongs S, Thompson L, Iverson G, Heaton R. Wisconsin Card Sorting Test-64 Card Version: Professional Manual. Odessa, FL: Psychological Assessment Resources; 2000.
43. Wechsler D. WMS-III: Wechsler Memory Scale Administration and Scoring Manual. San Antonio, TX: Psychological Corporation; 1997.
44. Wechsler D. WAIS-III: Wechsler Adult Intelligence Scale Administration and Scoring Manual. San Antonio, TX: Psychological Corporation; 1997.
45. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. PMS 1958 Dec;8(7):271. [doi: 10.2466/PMS.8.7.271-276]
46. Tombaugh TN, Kozak J, Rees L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol 1999 Feb;14(2):167-177. [Medline: 14590600]
47. Strauss E, Sherman E, Spreen O. A compendium of neuropsychological tests: administration, norms, and commentary. Oxford: Oxford University Press; 2006.
48. Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, CHARTER Group. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010 Dec 07;75(23):2087-2096 [FREE Full text] [doi: 10.1212/WNL.0b013e318200d727] [Medline: 21135382]
49. Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, HNRC Group. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 2004 May;26(3):307-319. [doi: 10.1080/13803390490510031] [Medline: 15512922]
50. Blackstone K, Moore DJ, Heaton RK, Franklin DR, Woods SP, Clifford DB, CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Group. Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning. J Int Neuropsychol Soc 2012 Jan;18(1):79-88 [FREE Full text] [doi: 10.1017/S135561771100141X] [Medline: 22114912]
51. Carey C, Woods S, Rippeth J, Gonzalez R, Moore D, Marcotte T, HNRC Group. Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. Clin Neuropsychol 2004 May;18(2):234-248. [doi: 10.1080/13854040490501448] [Medline: 15587671]